#Biopreservation Market
Explore tagged Tumblr posts
organicmarketresearch1 · 7 months ago
Text
Global Biopreservation Market Size, Share, Trends, Growth & Industry 2032
Tumblr media
Global Biopreservation market size was USD 3.11 billion in 2023 and the market is projected to touch USD 23.73 billion by 2032, at a CAGR of 25.33 % during the forecast period. Biopreservation refers to keeping alive of biological samples, cells, tissues and organs in a state of stability through cooling or freezing them so as to prolong their shelf life and retain their quality for use in future. It is very important to different sectors such as healthcare, pharmaceuticals and R&D where there is need for such materials to be kept for conducting tests or treatments or even transplanting an organ. Biopreservation market is made up of various types of products and services aimed at making this process easier including specialized storage devices, chemicals used for preventing spoilage known as cryoprotectants together with solutions which keep them alive known as preservation media among others which fall under sample management aspects or transport in different ways or even departments in specific institutions.
Recent years have witnessed a substantial increase in the global biopreservation market owing to a number of different factors. Demand for specific drugs and treatments coupled with regenerative surgeries that necessitate personal data storage on life supporting materials is one primary force creating an impact on this trend. Moreover, there is growing rates of chronic illnesses development along with rising counts of organ transplant procedures which has led to the demand for efficient biopreservation methods. However, obstacles like regulations, ethics, and expensive storage facilities seem to be preventing the market from growing. The global biopreservation market is projected to grow in the future as research into improving biopreservation techniques continues and their application area broadens, this will provide an opportunity for those concerned in healthcare industries.
Global Biopreservation report scope and segmentation.
Report Attribute
Details
Base Year
2023
Forecast Years
2024–2032
Estimated Market Value (2023)
USD 3.11 Billion
Projected Market Value (2032)
USD 23.73 Billion
Segments Covered
By Product, By Application Area, By End User, & By Region.
Forecast Units
Value (USD Million or Billion)
Quantitative Units
Revenue in USD million/billion and CAGR from 2024 to 2032.
Regions Covered
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Countries Covered
U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Australia, Brazil, Argentina, GCC Countries, and South Africa, among others.
Download Free Sample Report
Global Biopreservation dynamics
There are several key factors driving the biopreservation market, one of which is increase in the demand for personalized medicine and regenerative therapies. This results in the necessity to preserve individualized biologic samples. This means that as more precise treatments are being designed for specific patients, there is an urgent need for proven biopreservation techniques to keep these samples. Furthermore, numerous other factors account for the expanding market for biopreservation solutions which is promoted by the increasing number of patients with chronic conditions as well as growing organ transplantations globally. Many people are now in need of long-term treatment such as regular medical care, then this implies a rise in the use of conserved living things for scientific study, detection, and treatment.
Similarly, biotechnology and cell therapy research can change the biopreservation market. Furthermore, given that stem cell therapy and gene editing present new opportunities, protecting biological samples is given much attention to aid in continuous research and development efforts. The world is driven by the need for new biopreservation technologies and services designed to preserve various biological materials alive and functioning. Moreover, these collaborations among academia, industry and government have played a significant role in enhancing knowledge sharing, resource availability, funds provision among others in order to support research on biopreservation.
Get Complete Report: https://organicmarketresearch.com/global-biopreservation-market
Global Biopreservation drivers
Rise in Personalized Medicine
Biopreservation market gains a lot due to the strong spike in favour of personalized medicine a medical trend that involves tailoring treatments to the individual patient’s genetic composition. This form of medicine calls for storing bodily fluids taken from a patient for future use during diagnosis or research. The rise in awareness about genetic factors determining disease susceptibility and response to treatments leads to a growing need for biopreservation solutions to hold these examples. This phenomenon does not only encourage the utilization of biopreservation techniques in health care, but also brings together biobanks with research organizations and pharmaceutical firms in order to create targeted treatments.
Advancements in Biotechnology
The demand for innovative biopreservation solutions is driven by continuous advancements in biotechnology especially in cell therapy, regenerative medicine, and tissue engineering areas. Maintaining the viability and functionality of live cells and tissues used for new therapeutic modalities being explored in the research community requires specific approaches in their preservation. Induced pluripotent stem cells (iPSCs) have revolutionized research into effective therapies. They need precise cryopreservation procedures, however, for the cell to remain intact when stored or defrosted. In view of the above, biopreservation industry stakeholders should anticipate an upward trajectory as biology burgeons and advanced therapeutics demand top of the range conservation methods.
Restraints:
Regulatory Constraints
Regulatory compliance is indeed a challenge that the market of biopreservation is facing more so regarding the storage and transportation of biological samples. As a result of these regulations and guidelines put in place, preserved specimens have to be handled, labelled and documented in accordance with stringent measures which in turn make operations in biopreservation expensive and complex. Observing international standards such as Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) is key but can pose a challenge to smaller players or players operating in multiple jurisdictions.
High Cost of Specialized Equipment
The expensive characteristic of specified biopreservation equipment like ultra-low temperature freezers, automated storage systems and cryopreservation tanks have been an enormous obstacle to market expansion. It requires a lot of funds to establish and keep running biobanks or biorepositories that have latest facilities for preservation purposes. Additionally, the present operational costs like energy consumption and maintenance increases the cost hence limiting access to advanced solutions for biopreservation especially in low-resource contexts.
Opportunities:
Expansion of Biobanking Initiatives
The increasing focus on personalized medicine and biomolecular exploration will provide opportunities for expanding global biobanking endeavours. Biobanks are essential in scientific studies, particularly in sample preservation which boosts the need for bio-preservation solutions. By creating complete biobanking networks, it will allow biopreservation providers to offer their services and technologies which have been facilitated by collaborative efforts among academic institutions, healthcare organizations and government agencies.
Segment Overview
By product, the biopreservation market is segmented into Equipment, and Biopreservation Media. Equipment includes a range of devices used for the storage and preservation of biological samples, such as ultra-low temperature freezers, liquid nitrogen tanks, and automated storage systems. These products create environments that are carefully controlled which help maintain the condition of cells, tissues, and organs for extended periods. Also, biopreservation media refers to solutions or mixtures created specifically for safeguarding biological matter from various agents while still allowing storage or shipment. Usually within them are found anti-freezes as well as anti-oxidants together with other preservatives used in order to reduce injury imposed by such process as low temperature maintenance on living cells.
By application, the biopreservation market is segmented into drug discovery, biobanking, regenerative medicine, and other application areas. In drug discovery, biopreservation plays a crucial role in preserving cell lines, tissues, and biological samples used in screening assays, pharmacokinetic studies, and toxicity testing. Biobanking includes the collection, storage and distribution of biological specimens for research, clinical trials or diagnostic objectives, thus leading to an overwhelming demand for dependable biopreservation solutions which can preserve the integrity of samples. In regenerative medicine the conservation of stem cells, tissues and organs is a prerequisite for the production of new therapies to replace damaged tissues in patients. Biopreservation, besides, is also utilized in agriculture, veterinary medicine and environmental research where there is a demand for keeping samples for a long duration period to aid in scientific study as well as other works.
Global Biopreservation Overview by Region
With its well-established healthcare facilities, extensive research and development projects, as well as huge investments into biotechnology and pharmaceutical industries, North America is the leading market in the world. Biobanks, academic institutions and industry counterparts in collaboration have led to cutting edge innovations in biopreservation technologies and service delivery in this area. Initiatives promoting personalized medicine, regenerative therapies and biobanking networks as well as stringent regulatory standards has made Europe to follow closely in order to ensure the quality and safety of biopreserved samples which in turn fosters trust among stakeholders. The Asia Pacific region can undergo a swift expansion, arising from an upsurge of healthcare expenditure in this fast-growing industry, development of biopharmaceuticals and increased attention to preservation of living organisms in medicine. China, Japan, India, among others are putting up facilities for storing samples and studying preserved organisms in order to keep pace with rising needs of the developing countries. Furthermore, emerging economies in Latin America and the Middle East & Africa are witnessing rising investments in healthcare infrastructure and research capabilities, presenting untapped opportunities for market expansion.
Global Biopreservation market competitive landscape
The competitive landscape of the biopreservation market is identified by the presence of several key players, including Thermo Fisher Scientific Inc., Merck KGaA, GE Healthcare, BioLife Solutions Inc., and Avantor Inc. These companies dominate the market through their extensive product portfolios, strong distribution networks, and strategic partnerships. They focus on innovation to develop advanced biopreservation solutions that meet the evolving needs of healthcare, pharmaceutical, and research industries. Additionally, mergers and acquisitions play a significant role in influencing the competitive factors, enabling companies to expand their market presence and enhance their capabilities in biopreservation technologies and services. In addition, the biopreservation domain is being penetrated by small companies and new market participants who offer narrow specialized products for certain uses or market segments. This increases competition and prompts larger corporations that wish to remain competitive to spend more on R&D activities.
Global Biopreservation Recent Developments
November 2023, BioLife Solutions announced a fundraising of USD 10.4 million through a private placement by Casdin Capital. The funds are intended to support ongoing operations related to biopreservation media and other offerings.
October 2022, Azenta, Inc. completed the acquisition of B Medical Systems S.á r.l and its subsidiaries. B Medical Systems is renowned for providing temperature-controlled storage and transportation solutions crucial for delivering life-saving treatments worldwide.
July 2022, the inauguration of Cellutions BioStorage took place in Chennai, India. As a research-to-launch Cryopreservation Bank, Cellutions BioStorage offers comprehensive biomaterial storage and logistics services. It caters to biopharmaceutical firms seeking to outsource supply chain management throughout a product’s life cycle. The newly opened facility spans 25,000 square feet and boasts state-of-the-art infrastructure.
Contact Us: Mob : +91 9319642100 Noida One Tower Sec 62 Noida 201301 Sales : [email protected] Website : https://www.organicmarketresearch.com
0 notes
comparableau · 8 months ago
Text
Biopreservation Market was valued at US$ 5 billion in 2020 and is expected to grow at a CAGR of 14% over the forecast period (2021-2027)
0 notes
dineshpawar27 · 2 years ago
Text
0 notes
tbrcresearchreport · 2 years ago
Text
The Business Research Company offers biopreservation market market research report 2023 with industry size, share, segments and market growth
0 notes
latestmarketresearchnews · 1 month ago
Text
Biopreservation Industry Research Report 2030 by Key Growth Drivers, Leading Players Review
The global biopreservation market, valued at USD 2.18 billion in 2022, is poised for significant growth, with an anticipated compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. Biopreservation techniques are widely adopted in hospitals, laboratories, and research institutions for preserving biological specimens such as stem cells, tissues, DNA, and organs. These techniques ensure the longevity and functionality of samples, enabling advancements in medical research and treatment. The market benefits from substantial funding by government bodies and private organizations. These funds facilitate research and development (R&D) activities and drive advancements in biopreservation technologies.
The growing focus on life sciences research and clinical studies has led to innovations in preservation technologies. Companies like BioLife Solutions are expanding their portfolios. In April 2021, BioLife launched a high-capacity controlled freezer tailored for the cell and gene therapy market, addressing the growing demand in this segment. Innovative solutions are reducing the complexity and costs associated with biopreservation. The introduction of multiplex cellular imaging platforms enables better analysis of disease progression, paving the way for tailored diagnostics and treatments in areas like cardiology, gynecology, and point-of-care applications.
The global biopreservation market is on a robust growth trajectory, fueled by advancements in technology, increased funding, and rising demand for biologics and biospecimens. While North America leads the market due to its advanced infrastructure and strong research ecosystem, Asia Pacific is emerging as a dynamic region with rapid adoption of biopreservation techniques. Strategic initiatives by key players and government support are expected to further drive the market’s expansion, positioning biopreservation as a critical component in the future of healthcare and life sciences.
Gather more insights about the market drivers, restrains and growth of the Biopreservation Market
Regional Insights:
North America Biopreservation Market Trends
North America accounted for 45.00% of global revenue in 2022, driven by advanced biomedical research and innovative therapies.
Key Growth Factors:
High prevalence of chronic diseases requiring biopreservation for treatment.
Strong support from organizations like the National Institutes of Health (NIH) and National Cancer Institute (NCI).
Biobanks in the U.S. play a pivotal role in supporting research and clinical trials, further boosting demand for biopreservation technologies.
Asia Pacific Biopreservation Market Trends
Asia Pacific is projected to grow at a CAGR of 30.47% over the forecast period.
Key Drivers:
Rising funding for bio-banking techniques.
Increasing collaborations and partnerships to develop advanced biopreservation services.
Governments in this region are actively investing in R&D and promoting public-private partnerships to bolster the adoption of biopreservation.
Browse through Grand View Research's Category Biotechnology Industry Research Reports.
The global automated and closed cell therapy processing systems market size was valued at USD 1.41 billion in 2024 and is projected to grow at a CAGR of 19.8% from 2025 to 2030.
The global cell culture media storage containers market size was estimated at USD 2.11 billion in 2024 and is projected to witness a CAGR of 12.55% from 2025 to 2030.
Key Companies & Market Share Insights:
The biopreservation market is highly competitive, with major players focusing on strategic initiatives to maintain their market positions. Common strategies include:
Geographical Expansion: Companies are entering untapped markets to capitalize on growth opportunities.
Partnerships and Collaborations: Key players are joining forces with research institutions and governments to expand their services.
In January 2023, the Hamad Medical Corporation and Qatar BioBank launched a new tissue biobank service. This initiative provides researchers with access to high-quality tissue samples, highlighting the growing importance of biobanks in advancing medical research.
Key Biopreservation Companies:
Azenta US, Inc.
Biomatrica, Inc.
BioLife Solutions
MVE Biological Solutions
LabVantage Solutions, Inc.
Taylor-Wharton.
Thermo Fisher Scientific, Inc.
Panasonic Corporation
X-Therma Inc.
Stirling Ultracold 
Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.
0 notes
researchreportinsight · 1 month ago
Text
Biopreservation Industry 2030 Trends, Growth, Revenue, Outlook and Future Estimation
The global biopreservation market, valued at USD 2.18 billion in 2022, is poised for significant growth, with an anticipated compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. Biopreservation techniques are widely adopted in hospitals, laboratories, and research institutions for preserving biological specimens such as stem cells, tissues, DNA, and organs. These techniques ensure the longevity and functionality of samples, enabling advancements in medical research and treatment. The market benefits from substantial funding by government bodies and private organizations. These funds facilitate research and development (R&D) activities and drive advancements in biopreservation technologies.
The growing focus on life sciences research and clinical studies has led to innovations in preservation technologies. Companies like BioLife Solutions are expanding their portfolios. In April 2021, BioLife launched a high-capacity controlled freezer tailored for the cell and gene therapy market, addressing the growing demand in this segment. Innovative solutions are reducing the complexity and costs associated with biopreservation. The introduction of multiplex cellular imaging platforms enables better analysis of disease progression, paving the way for tailored diagnostics and treatments in areas like cardiology, gynecology, and point-of-care applications.
The global biopreservation market is on a robust growth trajectory, fueled by advancements in technology, increased funding, and rising demand for biologics and biospecimens. While North America leads the market due to its advanced infrastructure and strong research ecosystem, Asia Pacific is emerging as a dynamic region with rapid adoption of biopreservation techniques. Strategic initiatives by key players and government support are expected to further drive the market’s expansion, positioning biopreservation as a critical component in the future of healthcare and life sciences.
Gather more insights about the market drivers, restrains and growth of the Biopreservation Market
Regional Insights:
North America Biopreservation Market Trends
North America accounted for 45.00% of global revenue in 2022, driven by advanced biomedical research and innovative therapies.
Key Growth Factors:
High prevalence of chronic diseases requiring biopreservation for treatment.
Strong support from organizations like the National Institutes of Health (NIH) and National Cancer Institute (NCI).
Biobanks in the U.S. play a pivotal role in supporting research and clinical trials, further boosting demand for biopreservation technologies.
Asia Pacific Biopreservation Market Trends
Asia Pacific is projected to grow at a CAGR of 30.47% over the forecast period.
Key Drivers:
Rising funding for bio-banking techniques.
Increasing collaborations and partnerships to develop advanced biopreservation services.
Governments in this region are actively investing in R&D and promoting public-private partnerships to bolster the adoption of biopreservation.
Browse through Grand View Research's Category Biotechnology Industry Research Reports.
The global automated and closed cell therapy processing systems market size was valued at USD 1.41 billion in 2024 and is projected to grow at a CAGR of 19.8% from 2025 to 2030.
The global cell culture media storage containers market size was estimated at USD 2.11 billion in 2024 and is projected to witness a CAGR of 12.55% from 2025 to 2030.
Key Companies & Market Share Insights:
The biopreservation market is highly competitive, with major players focusing on strategic initiatives to maintain their market positions. Common strategies include:
Geographical Expansion: Companies are entering untapped markets to capitalize on growth opportunities.
Partnerships and Collaborations: Key players are joining forces with research institutions and governments to expand their services.
In January 2023, the Hamad Medical Corporation and Qatar BioBank launched a new tissue biobank service. This initiative provides researchers with access to high-quality tissue samples, highlighting the growing importance of biobanks in advancing medical research.
Key Biopreservation Companies:
Azenta US, Inc.
Biomatrica, Inc.
BioLife Solutions
MVE Biological Solutions
LabVantage Solutions, Inc.
Taylor-Wharton.
Thermo Fisher Scientific, Inc.
Panasonic Corporation
X-Therma Inc.
Stirling Ultracold 
Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.
0 notes
Text
Biopreservation Industry 2030 Outlook by Growth Rate, Trends, Size and Opportunities
The global biopreservation market, valued at USD 2.18 billion in 2022, is poised for significant growth, with an anticipated compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. Biopreservation techniques are widely adopted in hospitals, laboratories, and research institutions for preserving biological specimens such as stem cells, tissues, DNA, and organs. These techniques ensure the…
0 notes
marketanalysisdata · 2 months ago
Text
Biopreservation Market Revenue, Share and Growth Rate to 2030
The global biopreservation market was valued at USD 2.18 billion in 2022, and it is expected to grow at an impressive compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. This growth is driven by various factors, including extensive applications in healthcare settings like hospitals and laboratories, increased funding from both government and private entities, and advancements in research and development, particularly in the development of new products. For instance, BioLife Solutions introduced a new high-capacity controlled freezer in April 2021, aimed at supporting the cell and gene therapy sector. This addition helped the company expand its product range within biopreservation. The COVID-19 pandemic initially posed challenges for the industry, with disruptions in supply chains, shortages of raw materials, and slowdowns in research activities. However, it also accelerated interest and investment in biologics and vaccine technologies, which ultimately increased the demand for biopreservation solutions, especially for biologics manufacturing and preservation.
Biopreservation is a technique that enables the maintenance of biological materials such as stem cells, DNA, tissues, and organs under controlled temperatures, extending their viability outside their natural environment. Advances in technology, including microarrays, hybrid predictive models, and various API algorithms, are helping to streamline the biopreservation process by reducing its time, cost, and complexity. Additionally, the development of multiplex cellular imaging platforms is expected to boost biopreservation capabilities, especially in supporting disease research. These imaging platforms allow for better analysis of disease progression and facilitate targeted diagnostic and treatment strategies, benefiting fields like cardiology, gynecology, and point-of-care medicine.
Gather more insights about the market drivers, restrains and growth of the Biopreservation Market
Demand for biopreservation has significantly increased in the research and development of biologics across various sectors, including immunotherapy, vaccine production, antibody development, enzyme technology, and bio-manufacturing of chemicals. This surge is partially due to the rising global prevalence of chronic diseases. For example, according to the Centers for Disease Control and Prevention (CDC), cardiovascular diseases and cancer remain among the leading causes of mortality in adults in the United States.
In addition, government and private investments in research and development have spurred significant advancements in the market. There is growing demand for preserving stem cells and creating new biological treatments and products, which has attracted considerable attention and funding from investors. The substantial healthcare spending in this sector is likely to fuel the market's growth in the coming years.
However, the expanding biopreservation market faces some challenges. Key issues include a shortage of skilled professionals, high costs for training, and limited standardization in cybersecurity measures for biopreservation software. These factors may pose risks to market growth by adding complexity and increasing costs for companies operating in this space.
Application Segmentation Insights:
In terms of applications, the biobanking segment held a significant portion of the global market, accounting for 70.65% in 2022. The increasing awareness of stem cell preservation, rising acceptance of sperm and egg banking, and the use of assisted reproductive technologies in animals have all contributed to the segment’s growth. Many pharmaceutical companies are now collaborating with biobanks and hospitals for tissue and biological sample preservation.
The regenerative medicine segment is expected to grow at a higher CAGR of 29.68% during the forecast period, driven by a strong demand for advanced bio-storage techniques. Innovations in specific preservation techniques are likely to further boost growth in this segment over the coming years.
Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.
0 notes
marketstudyreport · 2 months ago
Text
Biopreservation Market Competitive Landscape and Industry Analysis 2030
The global biopreservation market was valued at USD 2.18 billion in 2022, and it is expected to grow at an impressive compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. This growth is driven by various factors, including extensive applications in healthcare settings like hospitals and laboratories, increased funding from both government and private entities, and advancements in research and development, particularly in the development of new products. For instance, BioLife Solutions introduced a new high-capacity controlled freezer in April 2021, aimed at supporting the cell and gene therapy sector. This addition helped the company expand its product range within biopreservation. The COVID-19 pandemic initially posed challenges for the industry, with disruptions in supply chains, shortages of raw materials, and slowdowns in research activities. However, it also accelerated interest and investment in biologics and vaccine technologies, which ultimately increased the demand for biopreservation solutions, especially for biologics manufacturing and preservation.
Biopreservation is a technique that enables the maintenance of biological materials such as stem cells, DNA, tissues, and organs under controlled temperatures, extending their viability outside their natural environment. Advances in technology, including microarrays, hybrid predictive models, and various API algorithms, are helping to streamline the biopreservation process by reducing its time, cost, and complexity. Additionally, the development of multiplex cellular imaging platforms is expected to boost biopreservation capabilities, especially in supporting disease research. These imaging platforms allow for better analysis of disease progression and facilitate targeted diagnostic and treatment strategies, benefiting fields like cardiology, gynecology, and point-of-care medicine.
Gather more insights about the market drivers, restrains and growth of the Biopreservation Market
Demand for biopreservation has significantly increased in the research and development of biologics across various sectors, including immunotherapy, vaccine production, antibody development, enzyme technology, and bio-manufacturing of chemicals. This surge is partially due to the rising global prevalence of chronic diseases. For example, according to the Centers for Disease Control and Prevention (CDC), cardiovascular diseases and cancer remain among the leading causes of mortality in adults in the United States.
In addition, government and private investments in research and development have spurred significant advancements in the market. There is growing demand for preserving stem cells and creating new biological treatments and products, which has attracted considerable attention and funding from investors. The substantial healthcare spending in this sector is likely to fuel the market's growth in the coming years.
However, the expanding biopreservation market faces some challenges. Key issues include a shortage of skilled professionals, high costs for training, and limited standardization in cybersecurity measures for biopreservation software. These factors may pose risks to market growth by adding complexity and increasing costs for companies operating in this space.
Application Segmentation Insights:
In terms of applications, the biobanking segment held a significant portion of the global market, accounting for 70.65% in 2022. The increasing awareness of stem cell preservation, rising acceptance of sperm and egg banking, and the use of assisted reproductive technologies in animals have all contributed to the segment’s growth. Many pharmaceutical companies are now collaborating with biobanks and hospitals for tissue and biological sample preservation.
The regenerative medicine segment is expected to grow at a higher CAGR of 29.68% during the forecast period, driven by a strong demand for advanced bio-storage techniques. Innovations in specific preservation techniques are likely to further boost growth in this segment over the coming years.
Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.
0 notes
imirmarketresearch · 1 year ago
Text
0 notes
industrynewsupdates · 3 months ago
Text
Biopreservation Market Key Companies, Growth and Forecast Report, 2030
The global biopreservation market size was valued at USD 2.18 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. 
Biopreservation is experiencing growth due to various factors such as extensive usage in hospitals and labs, rising funding assistance from government and private partners in healthcare, an upsurge in research & development, and growing advancement in terms of product development. For example, in April 2021, BioLife Solutions launched a new high-capacity controlled freezer to cater to the cell and gene therapy market, which helped the company expand its existing product portfolio. The market experienced a major hindrance during the COVID-19 pandemic with supply chain issues, unavailability of raw materials, and hindrances in research activities among other reasons. However, the pandemic also accelerated the growth of novel biologics, and vaccine technologies. Due to these factors, opportunities for biologics manufacturing and preservation are anticipated to increase, thus generating further demand for biopreservation.
Biopreservation is a process that helps maintain the integrity and functionality of biological products such as stem cells, DNA, tissues, and organs under different temperatures, thereby prolonging their lifespan outside their natural environment. Technology innovations include microarrays or incorporation of a wide range of predictive models, such as hybrid models, and various API algorithms which help reduce the time, cost and complexity of the overall process. Furthermore, the advent of multiplex cellular imaging platforms is anticipated to enhance the biopreservation ability to help understand disease progression and suggest suitable diagnostic & treatment measures to follow, specifically for cardiology, gynecology, and point-of-care applications.
Gather more insights about the market drivers, restrains and growth of the Biopreservation Marke
Biopreservation Market Report Highlights
• By product, the equipment segment held the largest revenue share of over 78.75% in 2022 due to the rising demand for bio-banking to preserve stem cells, DNA, plasma, and tissue culture. Increasing demand for modified genetic material in the global market is also fueling the growth
• The bio-banking application segment held the largest revenue share in 2022. This can be attributed to rising awareness regarding stem cell preservation, increasing acceptance of sperm and egg banking, and utilization of assistant reproductive technology in animals
• North America dominated the global market in 2022 due to the advancement in biomedical research, the development of advanced therapies, and the upsurge in research activities related to DNA sequencing and bioinformatics
• Asia Pacific is expected to grow considerably in the future owing to rising investments in Asian countries and increasing partnerships and collaborations with key players
Browse through Grand View Research's Biotechnology Industry Research Reports.
• The global cancer stem cells market size was valued at USD 2.89 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 9.5% from 2024 to 2030.
• The global DNA methylation market size was valued at USD 1.47 billion in 2023. It is expected to expand at a compound annual growth rate (CAGR) of 14.1% from 2024 to 2030.
Biopreservation Market Segmentation
Grand View Research has segmented the global biopreservation market on the basis of product, application, and region:
Biopreservation Product Outlook (Revenue, USD Billion, 2018 - 2030)
• Equipment
o Freezers
o Refrigerators
o Consumables
o Vials
o Straws
o Microtiter Plates
o Bags
o Liquid Nitrogen
• Media
o Pre-formulated
o Home-brew
• Laboratory Information Management System (LIMS)
Biopreservation Application Outlook (Revenue, USD Billion, 2018 - 2030)
• Regenerative Medicine
o Cell Therapy
o Gene Therapy
o Others
• Bio-banking
o Human Eggs
o Human Sperms
o Veterinary IVF
• Drug Discovery
Biopreservation Regional Outlook (Revenue, USD Billion, 2018 - 2030)
• North America
o U.S.
o Canada
• Europe
o Germany
o U.K.
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
• Asia Pacific
o China
o Japan
o India
o Australia
o Thailand
o South Korea
• Latin America
o Brazil
o Mexico
o Argentina
• Middle East and Africa (MEA)
o South Africa
o Saudi Arabia
o UAE
o Kuwait
Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.
0 notes
healthcaredbmrnews · 1 year ago
Text
Tumblr media
0 notes
shrutijadhav2139 · 9 days ago
Text
Food Preservatives Market Overview: Key Factors Impacting Market Dynamics and Future Outlook
The food preservatives market plays a pivotal role in ensuring food safety, extending shelf life, and meeting the growing consumer demand for convenience and quality. With rapid advancements and shifting consumer preferences, the market is evolving to balance traditional practices with innovative approaches.
Tumblr media
Key Factors Impacting Market Dynamics
Rising Demand for Processed Foods Urbanization and busier lifestyles have fueled the demand for processed and packaged foods, which rely on preservatives to maintain freshness and prevent spoilage. This trend continues to be a significant driver of market growth.
Shift Toward Natural Ingredients Consumers increasingly prefer natural and clean-label products, leading to a surge in demand for plant-based and organic preservatives. This shift has encouraged manufacturers to explore natural alternatives to synthetic preservatives.
Regulatory Compliance Strict food safety regulations across regions are shaping the market. Manufacturers must adhere to stringent guidelines, particularly in Europe and North America, ensuring that preservatives meet safety and quality standards.
Technological Advancements Emerging technologies, such as biopreservation and high-pressure processing, are transforming food preservation methods. These innovations offer safer, more sustainable solutions, aligning with consumer health and environmental priorities.
Future Outlook
The food preservatives market is poised for robust growth, driven by clean-label trends, advancements in sustainable practices, and increasing global demand for packaged foods. Strategic investments in research, innovation, and regional expansion will be critical for manufacturers to address challenges and capitalize on opportunities in this evolving sector.
Request Sample PDF Report : https://www.pristinemarketinsights.com/get-free-sample-and-toc?rprtdtid=NTI1&RD=Food-Preservatives-Market-Report
0 notes
newsheadlinesnow · 3 months ago
Text
Biopreservation Market worth $7.1 billion by 2029 | MarketsandMarkets™
http://dlvr.it/TDkL5S
0 notes
columbianewsupdates · 3 months ago
Text
Biopreservation Market worth $7.1 billion by 2029 | MarketsandMarkets™
http://dlvr.it/TDkHWQ
0 notes
latestmarketresearchnews · 2 months ago
Text
Biopreservation Market Growth Drivers With Outlook And Opportunity Forecast To 2030
The global biopreservation market was valued at USD 2.18 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. The rapid growth of this market is driven by a variety of factors, including the extensive use of biopreservation in hospitals, research labs, and healthcare facilities. Increased funding from both government entities and private organizations in healthcare is bolstering this growth, alongside a rise in research and development activities. In addition, advancements in product development are contributing to the expanding market. For instance, BioLife Solutions introduced a high-capacity controlled freezer in April 2021, targeting the cell and gene therapy market, which enabled the company to extend its product offerings.
Despite the market's expansion, the COVID-19 pandemic posed significant challenges, such as supply chain disruptions, shortages of raw materials, and interruptions to research activities. However, the pandemic also accelerated the development of novel biologics and vaccine technologies, creating a surge in demand for biologics manufacturing and preservation. As a result, opportunities for biopreservation are expected to increase, further boosting the market.
Gather more insights about the market drivers, restrains and growth of the Biopreservation Market
Biopreservation involves maintaining the integrity and functionality of biological materials such as stem cells, DNA, tissues, and organs by storing them at specific temperatures. This process extends their viability outside of their natural environment. Recent technological innovations, including microarrays and the incorporation of predictive models like hybrid models and API algorithms, have significantly reduced the time, cost, and complexity of biopreservation processes. These technological advancements are enhancing efficiency and performance across the industry.
Moreover, multiplex cellular imaging platforms are emerging as a transformative technology in the biopreservation field. These platforms improve the ability to monitor disease progression and offer insights into suitable diagnostic and treatment measures. They are particularly useful for specific healthcare areas like cardiology, gynecology, and point-of-care diagnostics. As these innovations progress, the role of biopreservation in modern healthcare is expected to expand.
Product Segmentation Insights:
The equipment segment dominated the biopreservation market in 2022, accounting for 78.75% of the market share. This is largely due to the growing demand for bio-banking services, which are used to preserve stem cells, DNA, plasma, and tissue cultures. The ability of biopreservation equipment to provide adequate storage capacity while requiring minimal maintenance has contributed to the widespread adoption of these solutions. As more healthcare providers and research facilities adopt biopreservation technologies, the equipment segment is expected to continue its strong performance.
The media segment, although smaller in market share, has significant growth potential. It is a crucial element of the biopreservation process, ensuring that biological materials are preserved effectively. The media segment is projected to grow at a remarkable CAGR of 29.99% from 2023 to 2030. Media applications are becoming more sophisticated, offering features that enhance research by enabling better data sharing and analysis. These advancements allow researchers to improve their capabilities in diagnosing, monitoring, and treating various health conditions, which is expected to drive significant market growth over the forecast period. As a result, the media segment will play an increasingly important role in advancing the overall effectiveness and efficiency of biopreservation.
Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.
0 notes